Patrick Homer is an Advisory Industry Consultant within SAS Health & Life Sciences, where he helps organizations accelerate clinical innovation through advanced analytics, artificial intelligence, and data-driven decision-making. Working closely with product, marketing, and industry teams, Patrick focuses on bringing innovative solutions to market that address the evolving challenges of clinical development and healthcare transformation. Passionate about translating complex technology into real-world business outcomes, he regularly contributes to thought leadership initiatives exploring the future of AI, clinical analytics, and digital transformation in Life Sciences.
The high cost of pricing myopia When launching a pharmaceutical product, it’s not enough to negotiate the best reimbursable price for each local market. Overall financial performance will depend on successfully managing go-to-market strategies at the global level. That means determining the optimal price and launch sequence for all the
